The post-viral GPNMB + immune niche persists in long-term Covid, asthma, and COPD is a research paper published in medRxiv (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01AI130591-02
PARP9-DTX3L Control Of Viral Infection and Airway Disease
National Institutes of Health
Grant: 5UH2HL123429-02
Preclinical Development of an Anti-Mucus Drug
National Institutes of Health
Grant: 1R41HL149523-01
A New Small-Molecule Kinase Inhibitor for Airway Disease
National Institutes of Health
Grant: 5R35HL145242-02
Defining and Controlling Airway Disease
NIAID NIH HHS
Grant: R01 AI130591
NHLBI NIH HHS
Grant: R35 HL145242
NHLBI NIH HHS
Grant: R41 HL149523
NHLBI NIH HHS
Grant: UH2 HL123429
Fields of Study
Keywords